StoryFunding
Neuracle files for IPO on Shanghai Stock Exchange Science and Technology Innovation Board
Neuracle Technology filed for an IPO on Shanghai's STAR Market in June 2026, targeting to raise approximately 2.5 billion yuan. The offering highlights Neuracle's market position following NEO's commercial approval and positions the company as China's first publicly listed invasive BCI developer.